Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor

Author:

Hirano Kazufumi1,Chen Woei Shin1,Chueng Adeline L.W.1,Dunne Angela A.1,Seredenina Tamara2,Filippova Aleksandra2,Ramachandran Sumitra1,Bridges Angela3,Chaudry Laiq3,Pettman Gary3,Allan Craig3,Duncan Sarah1,Lee Kiew Ching1,Lim Jean1,Ma May Thu1,Ong Agnes B.1,Ye Nicole Y.1,Nasir Shabina1,Mulyanidewi Sri1,Aw Chiu Cheong1,Oon Pamela P.1,Liao Shihua4,Li Dizheng4,Johns Douglas G.5,Miller Neil D.1,Davies Ceri H.1,Browne Edward R.1,Matsuoka Yasuji1,Chen Deborah W.1,Jaquet Vincent2,Rutter A. Richard1

Affiliation:

1. Neural Pathways Discovery Performance Unit, Neurosciences Therapeutic Area, GlaxoSmithKline, Biopolis, Singapore.

2. Department of Pathology and Immunology, Medical School, Centre Médical Universitaire, University of Geneva, Geneva, Switzerland.

3. Platform Technology & Sciences Department, GlaxoSmithKline, Stevenage, United Kingdom.

4. Neuroimmunology Discovery Performance Unit, Neurosciences Therapeutic Area, GlaxoSmithKline, Shanghai, China.

5. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3